Skip to content
2000
Volume 18, Issue 2
  • ISSN: 2772-2708
  • E-ISSN: 2772-2716

Abstract

At present, no proven effective treatment is available for Lung Ischemia-reperfusion Injury (LIRI). Natural compounds offer promising prospects for developing new drugs to address various diseases. This study sought to explore the potential of Rebaudioside B (Reb B) as a treatment compound for LIRI, both and .

This study involved utilizing the human pulmonary alveolar cell line A549, consisting of epithelial type II cells, subjected to Oxygen-glucose Deprivation/recovery (OGD/R) for high-throughput cell viability screening. The aim was to identify the most promising candidate compounds. Additionally, an rat model of lung ischemia-reperfusion was employed to evaluate the potential protective effects of Reb B.

Through high-throughput screening, Reb B emerged as the most promising natural compound among those tested. In the A549 OGD/R models, Reb B exhibited a capacity to enhance cell viability by mitigating apoptosis. In the LIRI model, pre-treatment with Reb B notably decreased apoptotic cells, perivascular edema, and neutrophil infiltration within lung tissues. Furthermore, Reb B demonstrated its ability to attenuate lung inflammation associated with LIRI primarily by elevating IL-10 levels while reducing levels of IL-6, IL-8, and TNF-α.

The comprehensive outcomes strongly suggest Reb B's potential as a protective agent against LIRI. This effect is attributed to its inhibition of the mitochondrial apoptotic pathway and its ability to mitigate the inflammatory response.

© 2024 The Author(s). Published by Bentham Science Publisher. This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/raiad/10.2174/0127722708295154240327035857
2024-09-01
2024-10-22
Loading full text...

Full text loading...

/deliver/fulltext/raiad/18/2/RAIAD-18-2-156.html?itemId=/content/journals/raiad/10.2174/0127722708295154240327035857&mimeType=html&fmt=ahah

References

  1. FeiL. JingyuanX. FangteL. Preconditioning with rHMGB1 ameliorates lung ischemia–reperfusion injury by inhibiting alveolar macrophage pyroptosis via the Keap1/] Nrf2/HO-1 signaling pathway.J. Transl. Med.202018130110.1186/s12967‑020‑02467‑w32758258
    [Google Scholar]
  2. OshimaY. SakamotoS. YamasakiK. Desflurane inhalation before ischemia increases ischemia–reperfusion-induced vascular leakage in isolated rabbit lungs.Springerplus201651203110.1186/s40064‑016‑3741‑927995008
    [Google Scholar]
  3. HungK.Y. LiaoW.I. PaoH.P. WuS.Y. HuangK.L. ChuS.J. Targeting f-box protein fbxo3 attenuates lung injury induced by ischemia-reperfusion in rats.Front. Pharmacol.20191058310.3389/fphar.2019.0058331178737
    [Google Scholar]
  4. MoyoP. MugumbateG. EloffJ.N. LouwA.I. MaharajV.J. BirkholtzL.M. Natural products: A potential source of malaria transmission blocking drugs?Pharmaceuticals202013925110.3390/ph1309025132957668
    [Google Scholar]
  5. BorbélyP. MolnárÁ. ValyonE. The effect of foliar selenium (se) treatment on growth, photosynthesis, and oxidative-nitrosative signalling of stevia rebaudiana leaves.Antioxidants20211017210.3390/antiox1001007233429850
    [Google Scholar]
  6. te PoeleE.M. DevlamynckT. JägerM. Glucansucrase (mutant) enzymes from Lactobacillus reuteri 180 efficiently transglucosylate Stevia component rebaudioside A, resulting in a superior taste.Sci. Rep.201881151610.1038/s41598‑018‑19622‑529367749
    [Google Scholar]
  7. FayazS. SharmaR. RajputY.S. MannB. LataK. Estimation of steviol glycosides in food matrices by high performance liquid chromatography.J. Food Sci. Technol.20185583325333410.1007/s13197‑018‑3270‑330065444
    [Google Scholar]
  8. SaitoM. Chen-YoshikawaT.F. SuetsuguK. Pirfenidone alleviates lung ischemia-reperfusion injury in a rat model.J. Thorac. Cardiovasc. Surg.2019158128929610.1016/j.jtcvs.2018.08.09830385019
    [Google Scholar]
  9. SunG. HuC. MeiQ. Uncovering the cytochrome P450-catalyzed methylenedioxy bridge formation in streptovaricins biosynthesis.Nat. Commun.2020111450110.1038/s41467‑020‑18336‑532908132
    [Google Scholar]
  10. WeiJ. ZhangX. PanH. Eupafolin inhibits breast cancer cell proliferation and induces apoptosis by inhibiting the PI3K/Akt/mTOR pathway.Oncol. Lett.202121433210.3892/ol.2021.1259333692864
    [Google Scholar]
  11. BergerS.I. IyengarR. Network analyses in systems pharmacology.Bioinformatics200925192466247210.1093/bioinformatics/btp46519648136
    [Google Scholar]
  12. TristanC.A. OrmanogluP. SlameckaJ. Robotic high-throughput biomanufacturing and functional differentiation of human pluripotent stem cells.Stem Cell Reports202116123076309210.1016/j.stemcr.2021.11.00434861164
    [Google Scholar]
  13. KhareN. ChandraS. Stevioside mediated chemosensitization studies and cytotoxicity assay on breast cancer cell lines MDA-MB-231 and SKBR3.Saudi J. Biol. Sci.20192671596160110.1016/j.sjbs.2018.10.00931762632
    [Google Scholar]
  14. SheikhalipourM. EsmaielpourB. GohariG. Salt stress mitigation via the foliar application of chitosan-functionalized selenium and anatase titanium dioxide nanoparticles in stevia (stevia rebaudiana bertoni).Molecules20212613409010.3390/molecules2613409034279430
    [Google Scholar]
  15. BoonkaewwanC. AoM. ToskulkaoC. RaoM.C. Specific immunomodulatory and secretory activities of stevioside and steviol in intestinal cells.J. Agric. Food Chem.200856103777378410.1021/jf072681o18433103
    [Google Scholar]
  16. BoonkaewwanC. ToskulkaoC. VongsakulM. Anti-inflammatory and immunomodulatory activities of stevioside and its metabolite steviol on thp-1 cells.J. Agric. Food Chem.200654378578910.1021/jf052346516448183
    [Google Scholar]
  17. YuanH. WangJ. WangF. Mucin 1 gene silencing inhibits the growth of SMMC-7721 human hepatoma cells through Bax-mediated mitochondrial and caspase-8-mediated death receptor apoptotic pathways.Mol. Med. Rep.20151256782678810.3892/mmr.2015.432326398332
    [Google Scholar]
  18. KinaretP.A.S. NdikaJ. IlvesM. Toxicogenomic profiling of 28 nanomaterials in mouse airways.Adv. Sci.2021810200458810.1002/advs.20200458834026454
    [Google Scholar]
  19. ShiR. WangQ. OuyangY. WangQ. XiongX. Picfeltarraenin IA inhibits lipopolysaccharide-induced inflammatory cytokine production by the nuclear factor-κB pathway in human pulmonary epithelial A549 cells.Oncol. Lett.20161121195120010.3892/ol.2015.403726893718
    [Google Scholar]
  20. AzevedoM.L.V. ZanchettinA.C. Vaz de PaulaC.B. Lung neutrophilic recruitment and il-8/il-17a tissue expression in COVID-19.Front. Immunol.20211265635010.3389/fimmu.2021.65635033868301
    [Google Scholar]
  21. WeiL. LiJ. HanZ. ChenZ. ZhangQ. Silencing of lncRNA malat1 prevents inflammatory injury after lung transplant ischemia-reperfusion by downregulation of il-8 via p300.Mol. Ther. Nucleic Acids20191828529710.1016/j.omtn.2019.05.00931604167
    [Google Scholar]
  22. NagataK. NishiyamaC. Il-10 in mast cell-mediated immune responses: Anti-inflammatory and proinflammatory roles.Int. J. Mol. Sci.2021229497210.3390/ijms2209497234067047
    [Google Scholar]
  23. MachucaT.N. CypelM. BonatoR. YeungJ.C. ChunY.-M. JuvetS. GuanZ. HwangD.H. ChenM. SaitoT. HarmantasC. DavidsonB.L. WaddellT.K. LiuM. KeshavjeeS. Safety and efficacy of ex vivo donor lung adenoviral il-10 gene therapy in a large animal lung transplant survival model.Hum. Gene Ther.20172897576510.1089/hum.2016.07028052693
    [Google Scholar]
/content/journals/raiad/10.2174/0127722708295154240327035857
Loading
/content/journals/raiad/10.2174/0127722708295154240327035857
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test